Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) is set to release its earnings data after the market closes on Tuesday, May 7th.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last posted its earnings results on Thursday, February 15th. The company reported $3.10 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The firm had revenue of $681.18 million during the quarter.
Bio-Rad Laboratories Stock Performance
BIO.B remained flat at $279.91 during trading hours on Tuesday. 2 shares of the company traded hands, compared to its average volume of 87. The firm has a 50 day moving average of $326.03 and a 200-day moving average of $316.86. The company has a debt-to-equity ratio of 0.14, a quick ratio of 4.34 and a current ratio of 5.83. Bio-Rad Laboratories has a 12 month low of $271.00 and a 12 month high of $467.95.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Further Reading
- Five stocks we like better than Bio-Rad Laboratories
- The 3 Best Fintech Stocks to Buy Now
- McDonald’s Trend Following Signal is an Opportunity Today
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
- What is the Hang Seng index?
- Did the Rally in Coca-Cola Company Stock Just Fizzle Out?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.